Medscape Medical News

 
 
  • IDWeek 2020 Around the World in 24 Hours: A Snapshot of COVID's Global Havoc IDWeek's 24-hour 'Chasing the Sun' session on advances in the diagnosis and treatment of COVID-19 around the word was covered by a team of Medscape reporters.
  • Healthcare Workers Ask OSHA for More Oversight on COVID-19 Safety With such minimal oversight from OSHA, some union leaders and legislators say it's actually more dangerous than not having workplace safety enforcement at all.
  • KidneyWeek 2020 Novel Drug Slows Progression of Diabetic Kidney Disease Finerenone, a selective, nonsteroidal mineralocorticoid receptor antagonist, significantly reduced both renal and cardiovascular events, with good tolerability, in the FIDELIO-DKD trial.
  • CHEST 2020 Unneeded Meds at Discharge Could Cause Harm Too many patients are discharged from the hospital with unneeded bronchodilators and acid suppressant agents, highlighting the need for medication reconciliation.
  • Opinion: Bailout US Cancer Care The authors argue that 'ensuring the short-term solvency of independent practices is critical to preserving patients' access to cancer care.'
  • IDWeek 2020 Two Thirds of US Teens Fail to Get Needed Vaccines Completion rates vary from 11.3% in Idaho to 56.4% in Rhode Island. Provider visits at age 16 or 17 and mandates for meningococcal ACWY are keys to uptake, researcher says.
  • TCT 2020 Off Target: Optimal Post-PCI FFR Often Missed Despite angiographically acceptable PCI results, the majority of patients had a physiologically suboptimal outcome based on postprocedure FFR.
  • ICNA-CNS 2020 Long-Term Benefits From Nusinersen for Presymptomatic SMA Nusinersen provides continued, long-term benefits to infants with spinal muscular atrophy who begin treatment before symptom onset, according to an analysis.
  • ICNA-CNS 2020 CBD for LGS: Fewer Seizures, Increased Thrombocytopenia Risk Two recent analyses of highly purified cannabidiol (CBD) used to reduce seizures in Lennox Gastaut syndrome (LGS) have shown it is effective in reducing seizures for 3 years.
  • The Ally in the Waiting Room The waiting room is where a patient's loved ones often are and they, sometimes more than anyone, can unlock the path to a patient's quicker recovery.
  • Decision on Race Multiplier in CKD in Blacks 'Has Real Consequences' Dropping the eGFR multiplier for African Americans produced a 33% hike in those assigned to a more severe stage of chronic kidney disease. But whether or not to keep the adjustment remains unclear, say experts.
  • TCT 2020 Stellarex Paclitaxel Coated Balloon Safe, Durable in PAD Moving ahead with paclitaxel balloons in the periphery: Calls for comparative effectiveness trials, like those for coronary stents, followed release of long-term postmarket data from ILLUMINATE-Global.
  • New Thermography Shows Efficacy for Breast Cancer Screening Thermography aided by diagnostic software may provide an alternative to mammography in resource-poor countries where standard breast cancer screening is not available or affordable, say researchers.
  • AAP 2020 ADHD Care Is Essential and Doable in Pediatric Practice Integrating ADHD care into practice work flows is vitally important for all practitioners who care for children, said Herschel Lessin, MD.
  • CHEST 2020 Statins Linked to Lower Mortality Risk From Sepsis Mortality rates are lower in hospitalized sepsis patients who use statins than in those who do not, new research shows.
  • ICNA-CNS 2020 Worldwide Measles Vaccination Is Flagging After almost 2 decades of progress, the global state of measles vaccination and measles mortality is deteriorating.
  • Apples, Berries, and Tea: Flavanols Effective for BP Lowering? A high intake of dietary flavanols, compounds found in plant-based foods, is associated with significantly lower systolic and diastolic blood pressure, new research shows.
  • COVID-19 a New Opportunity for Suicide Prevention Even with the negative mental health impact of the pandemic, an uptick in suicide is not inevitable if suicide prevention lessons are heeded, one expert says.
  • COVID-19: Convalescent Plasma Falls Short in Phase 2 Trial Convalescent plasma may not prevent progression to severe disease or reduce mortality risk in hospitalized patients with moderate COVID-19, based on a phase 2 trial involving more than 400 patients.
  • EEG May Guide Optimal Treatment for PTSD, Major Depression Connectivity patterns on EEG reveal different subtypes of PTSD and major depression that may respond differently to psychotherapy, antidepressants, or brain stimulation.